维普期刊资源整合服务平台（V6.5）

35篇 您的检索式：作者名="TAPLIN ME"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Phase 1-2 study of MDV3100 in pre-and post-decetaxel advanced prostate cancer:long-term efficacy results显示文摘	Higano CBT Yu E Taplin ME		0，，4：	1
2	Androgen receptor muta- tions in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663 显示文摘	Taplin ME Rajeshkumar B Halabi S	2003	Clin Oncol2003，21，：	1
3	Mutation of the androgen receptor gene in metastatic androgen-independent prostate cancer 显示文摘	Taplin ME Bubley GJ Shuster TD	1995	New Engl J Med1995，332，：	1
4	Secondary hormone therapy for castration-resistant prostate cancer显示文摘	TAPLIN ME	2013	Oncology2013，27，5：	1
5	Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer显示文摘	TAPLIN ME BUBLEY GJ SHUSTER TD	1995	N Engl J Med1995，332，21：	1
6	Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist显示文摘	TAPLIN ME BUBLEY GJ KO YJ	1999	CancerRes1999，59，11：	1
7	Drug insight: role of the androgen receptor in the development and progression of prostate cancer 显示文摘	Taplin ME		Nat Clin Pract Oncol0，4，4：	1
8	Androgen receptor: a ked rnoleetde in the progression of prostate cancer to hormone independence 显示文摘	Taplin ME Balk SP	2004	J Cell Biochem2004，91，3：	1
9	Drug insight:role of the androgen receptor in the development and progression of prostate cancer显示文摘	Taplin ME	2007	Nat Clin Pract Oncol2007，4，：	1
10	Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist显示文摘	Bubley GJ Ko Y J	1999	Cancer Res1999，59，：	1
11	Clinical review 134:The endocrinology of prostate cancer显示文摘	Taplin ME Ho SM	2001	J Clin Endocrinol Metab2001，86，8：	1
12	Androgen receptor mutations in androgen-independent prostate canc- er: Cancer and Leukemia Group B Study 9663 显示文摘	Taplin ME Rajeshkumar B Halabi S	2003	J Clin Oncol2003，21，14：	1
13	Mutation of the androgen-receptor gene in metastatic androgen-inde- pendent prostate cancer 显示文摘	Taplin ME Bubley GJ Shuster TD	1995	N Engl J IVied1995，332，21：	1
14	Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist显示文摘	TAPLIN ME BUBLEY GJ KO YJ	1999	Cancer Res1999，59，11：	1
15	Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist 显示文摘	Taplin ME Bubley GJ Ko Y J	1999	Cancer Res1999，59，11：	1
16	Androgen receptor mutations in androgen-independent prostate cancer:cancer and leukemia group B study 9663显示文摘	TAPLIN ME RAJESHKUMAR B HALABI S	2003	J Clin Oncol2003，21，14：	1
17	Clnical review134: The endocrinology of prostate Cancer 显示文摘	TAPLIN ME HO SM	2001	J Clin Endocrinol Metab2001，86，34：	1
18	Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer显示文摘	Petrylak DP Tangen CM Hussain MH Lara PN Jr Jones JA Taplin ME	2004	N Engl J Med2004，351，15：	1
19	Selection for androgen receptor mutation in prostate cancers treated with androgen antagonist显示文摘	Taplin ME Bubley GJ Ko YJ	1999	Cancer Res1999，59，11：	1
20	Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist显示文摘	Taplin ME Bubley GJ Ko YJ	1999	Cancer Res1999，59，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示